Fermenta Biotech Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 1,007.17 million compared to INR 1,021.2 million a year ago. Net loss was INR 80.51 million compared to net income of INR 44.99 million a year ago. Basic loss per share from continuing operations was INR 2.79 compared to basic earnings per share from continuing operations of INR 1.56 a year ago. Diluted loss per share from continuing operations was INR 2.79 compared to diluted earnings per share from continuing operations of INR 1.56 a year ago.
For the six months, sales was INR 1,964.51 million compared to INR 2,135.85 million a year ago. Net loss was INR 103.61 million compared to net income of INR 158.11 million a year ago. Basic loss per share from continuing operations was INR 3.59 compared to basic earnings per share from continuing operations of INR 5.48 a year ago. Diluted loss per share from continuing operations was INR 3.59 compared to diluted earnings per share from continuing operations of INR 5.47 a year ago.